Transcription of Lipids
{{id}} {{{paragraph}}}
Dec 2016 MINISTRY OF HEALTHSINGAPOREL ipidsISBN 978-981-11-1845-6 Ministry of Health, SingaporeCollege of Medicine Building16 College RoadSingapore 169854 Tel (65) 6325 9220 Fax (65) 6224 Clinical Practice Guidelines 2/2016 Endocrine & Metabolic Societyof SingaporeSingaporeCardiac SocietyChapter of FamilyMedicine PhysiciansAcademy of Medicine, SingaporeCollege of Family Physicians, SingaporeChapter of EndocrinologistsChapter of General PhysiciansCollege of Physicians, SingaporeLevels of evidence and grades of recommendationLevels of evidenceGrades of recommendationLevelType of Evidence1+ + high quality meta-analyses, systematic reviews of randomised controlled trials (RCTs), or RCTs with a very low risk of bias1+Well conducted meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of bias1-Meta-analyses, systematic reviews of RCTs, or RCTs with a high risk of bias2+ + high quality systematic reviews of case control or cohort studies.
of high intensity statins for individuals at the highest risk of coronary artery disease, and the roles of non-statin lipid lowering therapies has been clarified through a ... risk in adults recommended moderate intensity statin therapy, e.g. simvastatin 20-40 mg or its equivalent
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}